GitLab stock price target lowered to $65 by FBN Securities on mixed results

GitLab Inc (GTLB) reported robust fiscal second-quarter revenue growth of 29% year-over-year and a significant non-GAAP operating margin improvement to 16.8%, alongside impressive 88.64% gross profit margins, largely exceeding profitability estimates. Despite some top-line metrics like RPO slightly missing expectations, the company maintains a strong balance sheet. However, the recent CFO departure and subsequent mixed analyst reactions, with several firms lowering price targets, underscore a cautious outlook and divided sentiment on GitLab's near-term prospects.

Analysis

GitLab Inc. (GTLB) delivered a dichotomous fiscal second quarter, marked by significant outperformance on profitability metrics but softer-than-expected forward-looking growth indicators. The company reported a robust 29% year-over-year revenue increase, surpassing consensus by 4%, and achieved an impressive non-GAAP operating margin of 16.8%, a 6.8 percentage point year-over-year expansion that was well ahead of expectations. This margin strength was fueled by disciplined expense management, with non-GAAP operating expenses growing only 17%, and is supported by a strong balance sheet holding more cash than debt and a gross profit margin of 88.64%. However, top-line momentum signals were less compelling; remaining performance obligations (RPO) grew 32%, missing some analyst estimates, and current RPO of $621.6 million fell slightly short of consensus. Compounding this mixed operational picture is the departure of the Chief Financial Officer to Snowflake, which has introduced leadership uncertainty and prompted a wave of cautious revisions from analysts. While firms like Truist and Piper Sandler maintain 'Buy' ratings, they have lowered their price targets to $55 and $70 respectively, reflecting a tempered near-term outlook.

Key Decisions for Investors

• Investors may consider the divergence between strong current profitability and mixed forward guidance as a key factor; the stock's performance will likely hinge on whether future billings and RPO growth can re-accelerate to match the impressive margin expansion.
• The departure of the CFO to a major competitor introduces a significant governance risk, and investors should closely monitor any updates on the CFO search and guidance stability in the upcoming quarter before initiating or adding to positions.
• Given the lowered price targets from multiple analysts despite maintained 'Buy' ratings, it may be prudent to wait for signs of stabilization in analyst sentiment and evidence of sustained top-line growth before viewing the current stock price as an undervalued entry point.